FDA Inspection
Aesculap IncAesculap Inc – FDA Inspection, Jun 13, 2018
Record Details
This FDA Inspection record concerns Aesculap Inc, with an inspection on June 13, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
- People
- Kathleen B. Swat (FDA Associated Person)
- Mary K. Concannon (Issuing Officer)
View Company Profile
ID · c9f80ead-069e-45e5-89ad-16f17bab6bf2
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1055539
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
Other FDA inspections of Aesculap Inc
4| Date | Classification | Office | Project area |
|---|---|---|---|
| September 14, 2016 | VAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
| October 23, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| August 9, 2013 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| July 13, 2010 | VAI | Center for Devices and Radiological Health | Compliance: Devices |
Other documents for Aesculap Inc
- FDA Inspection 986649 - 2016-09-14
- FDA Inspection 901818 - 2014-10-23
- FDA Inspection 843597 - 2013-08-09
- FDA Inspection 675706 - 2010-07-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.